Diversified Financial Services
Company Overview of Constellation Bancorp
Constellation Bancorp was acquired by CoreStates Financial Corp. in 1993. Constellation Bancorp provides commercial banking services through its subsidiary Constellation Bank, N.A. The company was founded in 1985 and is based in Elizabeth, New Jersey.
68 Broad Street
Elizabeth, NJ 07201-2206
Founded in 1985
Key Executives for Constellation Bancorp
Constellation Bancorp does not have any Key Executives recorded.
Constellation Bancorp Key Developments
Constellation Presents at 30th Annual Global Power Markets, Apr-14-2015 11:00 AM
Apr 13 15
Constellation Presents at 30th Annual Global Power Markets, Apr-14-2015 11:00 AM. Venue: Wynn Las Vegas, 3131 Las Vegas Blvd. South, Las Vegas, NV 89109, United States. Speakers: Andy Swaminathan, Senior Vice President, Portfolio Management and Strategy.
Constellation Presents at 16th Annual Financing US Power Conference, Oct-16-2014 09:15 AM
Sep 5 14
Constellation Presents at 16th Annual Financing US Power Conference, Oct-16-2014 09:15 AM. Venue: Crowne Plaza Times Square, New York, New York, United States. Speakers: Edward J. Quinn, President, Wholesale.
Constellation Expands Clinical Studies of CPI-0610
Aug 4 14
Constellation announced that it has initiated two additional clinical studies of its lead BET Inhibitor, CPI-0610. CPI-0610 has been progressing in a Phase 1 clinical trial in patients with lymphoma since September of 2013. As that trial continues, two new Phase 1 clinical trials of CPI-0610 were started in July of 2014. The first additional trial evaluates CPI-0610 in patients with multiple myeloma, while the second trial focuses on patients with acute leukemias or myelodysplastic syndrome. The expansion of the clinical evaluation of CPI-0610 to patients with these diseases is based on the high sensitivity of hematologic malignancies to BET inhibition in preclinical models, particularly in models of myeloma and acute leukemia. As a result of treating the first patients in both of these two new studies, Constellation earned a $1.5 MM milestone in its partnership with The Leukemia and Lymphoma Society (LLS). This external financial support from LLS enabled the expansion of the CPI-0610 clinical program into the three distinct indications being explored, with the hope of more rapidly and completely understanding which patients may benefit from this new approach to cancer treatment.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries